Lúpus eritematoso sistêmico: os impactos da polimedicação na cavidade bucal
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Systemic Lupus Erythematosus (SLE) is a multisystemic, idiopathic and
autoimmune chronic inflammatory disease that can lead to mucocutaneous,
rheumatological, neurological and renal involvement. The disordered activity of the
immune system exceeds the immunological tolerance and can cause damage to
several systems of the human body. Patients with SLE may require multiple
medications and the polypharmacy may be associated with oral effects. Objective: To
investigate the effects of polypharmacy on the oral health of individuals with SLE.
Methodology: Data collected from 46 patients, 17 from the control group and 29 being
treated for Systemic Lupus Erythematosus, include: age, race, sex, medications for
the treatment of SLE, various medications, indices (gingival, plaque and bleeding to
probing), number of teeth with probing greater than 3mm, CPOD, xerostomia and
number of missing, decayed and filled teeth. In addition, the total anticholinergic load
was calculated for each patient according to the drugs used. Results: The analyzes
show that the SLE group has a greater number of patients exposed to polypharmacy
(62.1%) and with a sum of anticholinergic load greater than zero (75.9%). It was also
possible to observe the existence of significant correlations between the anticholinergic
load and xerostomia (r=0.346 - low positive correlation) and with polypharmacy
(r=0.557 - moderate positive correlation). Conclusion: Patients in the SLE group are
more exposed to polypharmacy and have a higher total anticholinergic burden when
compared to others in the same group who do not fit into polypharmacy. The results of
this study reiterate the presence of oral involvement in patients conditioned to the
treatment of Systemic Lupus Erythematosus and also suggest that there is a need for
a new perspective that considers the risks that polypharmacy can generate to general
and oral health.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

